Stay informed with the latest updates for the inheritable blood disorders community.

Medical
CDC Findings Suggest Hemophilia Carriers Vulnerable to Joint Damage
CDC Findings Suggest Hemophilia Carriers Vulnerable to Joint Damage
NBDF & Community
Offensive Statement Removed From ABC Series Episode
Offensive Statement Removed From ABC Series Episode
NBDF & Community
Offensive Statement Removed From ABC Series Episode
ABC Hit Series Portrays Hemophilia as “Nasty Byproduct of Incest”
Medical
Small Study Shows Significant Progress in Hemophilia B Gene Therapy
Small Study Shows Significant Progress in Hemophilia B Gene Therapy
Industry
Bayer Responds to NHF-HFA Joint Statement
CSL Behring Announces Product Donations to WFH
Industry
Octapharma Announces Co-Pay Assistance for Wilate
Octapharma Announces Co-Pay Assistance for Wilate
Industry
FDA Grants Breakthrough Status to Genentech’s Investigational Therapy for Hemophilia A
Bayer Submits Application for Investigational Recombinant Factor VIII…
Advocacy & Legislative
Washington Days Draws a Crowd
Washington Days Draws a Crowd
Industry
Spark Reports Preliminary Data from Hemophilia A Gene Therapy Trial
Baxter Reports Gene Therapy Program Updates
NBDF & Community
Collaborating in Care Educational Modules Available Now
Collaborating in Care Educational Modules Available Now
Industry
Alnylam Announces Extension of Study for ALN-AT3
Biogen Idec and TIGET to Collaborate on Gene Therapy
Industry
OPKO Health Submits Application to FDA for Long-Acting Factor VIIa
OPKO Health Submits Application to FDA for Long-Acting Factor VIIa
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Inhibitors in Hemophilia Chapter Now Available in NHF’s…
Medical
Plant-Based Inhibitor Therapy Continues to Evolve
Plant-Based Inhibitor Therapy Continues to Evolve
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
PDF Now Available for Nurses’ Guide Chapter on von Willebrand Disease